K. Taniguchi

735 total citations
35 papers, 620 citations indexed

About

K. Taniguchi is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, K. Taniguchi has authored 35 papers receiving a total of 620 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Immunology, 11 papers in Oncology and 7 papers in Molecular Biology. Recurrent topics in K. Taniguchi's work include Immune Cell Function and Interaction (8 papers), Cancer Immunotherapy and Biomarkers (5 papers) and Lung Cancer Treatments and Mutations (5 papers). K. Taniguchi is often cited by papers focused on Immune Cell Function and Interaction (8 papers), Cancer Immunotherapy and Biomarkers (5 papers) and Lung Cancer Treatments and Mutations (5 papers). K. Taniguchi collaborates with scholars based in Japan, United States and Sweden. K. Taniguchi's co-authors include Rolf Kiessling, K Nomoto, Alvar Grönberg, Hans‐Gustaf Ljunggren, George Klein, Gerald E. Piontek, K Kärre, Petter Höglund, Klas Kärre and Max Petersson and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Immunology and Antimicrobial Agents and Chemotherapy.

In The Last Decade

K. Taniguchi

33 papers receiving 593 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
K. Taniguchi Japan 13 374 150 123 63 59 35 620
Christoph Scholz Germany 11 178 0.5× 150 1.0× 109 0.9× 64 1.0× 30 0.5× 25 477
S. Orbach‐Arbouys France 14 224 0.6× 139 0.9× 146 1.2× 85 1.3× 41 0.7× 75 653
Henrike L. Schieferdecker Germany 18 524 1.4× 98 0.7× 165 1.3× 154 2.4× 27 0.5× 27 847
Anna Maria Ongari Italy 12 247 0.7× 45 0.3× 76 0.6× 85 1.3× 26 0.4× 28 471
Betty J Nelson United States 9 298 0.8× 117 0.8× 184 1.5× 108 1.7× 56 0.9× 10 553
Kangkang Yang China 10 351 0.9× 91 0.6× 253 2.1× 85 1.3× 67 1.1× 18 674
Michel Pontet France 14 156 0.4× 58 0.4× 235 1.9× 96 1.5× 48 0.8× 26 529
Abbas Hawwari Saudi Arabia 19 636 1.7× 154 1.0× 334 2.7× 131 2.1× 68 1.2× 37 1.1k
Talveer S. Mandur Canada 9 284 0.8× 97 0.6× 128 1.0× 69 1.1× 41 0.7× 9 558
Jung Koo Youn South Korea 11 194 0.5× 103 0.7× 93 0.8× 67 1.1× 31 0.5× 30 410

Countries citing papers authored by K. Taniguchi

Since Specialization
Citations

This map shows the geographic impact of K. Taniguchi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K. Taniguchi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K. Taniguchi more than expected).

Fields of papers citing papers by K. Taniguchi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K. Taniguchi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K. Taniguchi. The network helps show where K. Taniguchi may publish in the future.

Co-authorship network of co-authors of K. Taniguchi

This figure shows the co-authorship network connecting the top 25 collaborators of K. Taniguchi. A scholar is included among the top collaborators of K. Taniguchi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K. Taniguchi. K. Taniguchi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Goto, Yasushi, Kodai Kawamura, Tatsuro Fukuhara, et al.. (2023). Health Care Resource Use Among Patients with Advanced Non–Small Cell Lung Cancer in Japan, 2017–2019. Current Therapeutic Research. 99. 100712–100712. 2 indexed citations
3.
Goto, Yasushi, Atsuhisa Tamura, Hirotaka Matsumoto, et al.. (2022). First-Line Pembrolizumab Monotherapy for Advanced NSCLC With Programmed Death-Ligand 1 Expression Greater Than or Equal to 50%: Real-World Study Including Older Patients in Japan. JTO Clinical and Research Reports. 3(9). 100397–100397. 7 indexed citations
4.
Nokihara, Hiroshi, Takashi Kijima, Toshihide Yokoyama, et al.. (2022). Real-World Treatments and Clinical Outcomes in Advanced NSCLC without Actionable Mutations after Introduction of Immunotherapy in Japan. Cancers. 14(12). 2846–2846. 5 indexed citations
5.
Yanagihara, Katsunori, Kosuke Kosai, Hiroshige Mikamo, et al.. (2020). Serotype distribution and antimicrobial susceptibility of Streptococcus pneumoniae associated with invasive pneumococcal disease among adults in Japan. International Journal of Infectious Diseases. 102. 260–268. 33 indexed citations
6.
Kato, Terufumi, Kiyoshi Mori, Koichi Minato, et al.. (2017). P1.06-021 Treatment Patterns and Healthcare Resource Use from a Retrospective Cohort of Japanese Patients with Advanced Non-Small Cell Lung Cancer. Journal of Thoracic Oncology. 12(1). S678–S678. 1 indexed citations
7.
Isobe, Hiroshi, Kiyoshi Mori, Koichi Minato, et al.. (2017). Real-world practice patterns for patients with advanced non-small cell lung cancer: multicenter retrospective cohort study in Japan. PubMed. Volume 8. 191–206. 16 indexed citations
8.
Izuhara, Kenji, Shoichiro Ohta, Hiroshi Shiraishi, et al.. (2009). The Mechanism of Mucus Production in Bronchial Asthma. Current Medicinal Chemistry. 16(22). 2867–2875. 51 indexed citations
9.
Taniguchi, K., Tsuneko Ono, Keiji Murakami, et al.. (2003). Novel Pseudomonas aeruginosa Gene That Suppresses Tolerance to Carbapenems. Antimicrobial Agents and Chemotherapy. 47(9). 2997–3001. 12 indexed citations
10.
Taniguchi, K., et al.. (1996). Drug-induced down-regulation of topoisomerase I in human epidermoid cancer cells resistant to saintopin and camptothecins.. PubMed. 56(10). 2348–54. 22 indexed citations
11.
Ido, Masaru, et al.. (1991). Differential growth inhibition of isoquinolinesulfonamides H-8 and H-7 towards multidrug-resistant P388 murine leukaemia cells. British Journal of Cancer. 64(6). 1103–1107. 11 indexed citations
12.
Taniguchi, K., et al.. (1988). AK cells were developed from NK cells during in vitro culture of allogeneic or F1 anti-parental stimulation: functional conversion in recognizing H-2 expression of target cells accompanied by phenotypical conversion.. PubMed. 64(4). 669–76. 2 indexed citations
13.
Tomooka, Suguru, Bazir Serushago, Yuichi Koga, K. Taniguchi, & K Nomoto. (1986). Indomethacin-induced sialic acid-mediated changes in surface markers from «cortical type» to «Medullary Type» in Murine Thymoma Line EL-4. Immunobiology. 171(4-5). 345–356. 7 indexed citations
14.
Piontek, Gerald E., K. Taniguchi, Hans‐Gustaf Ljunggren, et al.. (1985). YAC-1 MHC class I variants reveal an association between decreased NK sensitivity and increased H-2 expression after interferon treatment or in vivo passage.. The Journal of Immunology. 135(6). 4281–4288. 139 indexed citations
15.
Koga, Yasuhiro, et al.. (1985). Thymus-Dependent Increase in Number of T Cells in Parathymic Lymph Nodes Induced by the Biscoclaurine Alkaloid, Cepharanthine. Immunobiology. 170(4). 351–364. 6 indexed citations
16.
Koga, Yasuhiro, K. Taniguchi, & K Nomoto. (1984). Thymus-recruited Peritoneal Exudate T Lymphocytes. Immunobiology. 167(5). 495–505. 1 indexed citations
17.
Kawauchi, Hideyuki, K. Taniguchi, Chiharu Kubo, Yoshinori Shimamoto, & K Nomoto. (1983). The mechanism of reduction of cell-mediated cytotoxicity in neonatally thymectomized mice.. PubMed. 50(2). 199–205. 12 indexed citations
18.
Nomoto, K, Chiharu Kubo, K. Taniguchi, & Kenji Takeya. (1979). Direct cytotoxicity against chicken erythrocytes in mice. II. Nature of immunoglobulin on cytotoxic T lymphocytes.. PubMed. 37(4). 821–5. 2 indexed citations
19.
Kubo, Chiharu, K Nomoto, K. Taniguchi, et al.. (1979). Direct cytotoxicity against chicken erythrocytes in mice. III. Degrees of radiosensitivity and cross-reactivity of cytotoxicity, delayed hypersensitivity and antibody production.. PubMed. 37(4). 827–34. 3 indexed citations
20.
Nomoto, K, K. Taniguchi, Chiharu Kubo, & Kenji Takeya. (1978). Relationships among differentiated T-cell subpopulations. III. Radioresistance of delayed hypersensitivity to heterologous erythrocytes.. PubMed. 34(3). 517–21. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Christoph Scholz Breakdown of academic impact, for papers by S. Orbach‐Arbouys Breakdown of academic impact, for papers by Henrike L. Schieferdecker Breakdown of academic impact, for papers by Anna Maria Ongari Breakdown of academic impact, for papers by Betty J Nelson Breakdown of academic impact, for papers by Kangkang Yang Breakdown of academic impact, for papers by Michel Pontet Breakdown of academic impact, for papers by Abbas Hawwari Breakdown of academic impact, for papers by Talveer S. Mandur Breakdown of academic impact, for papers by Jung Koo Youn
Rankless by CCL
2026